Difference between revisions of "Dactinomycin (Cosmegen)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Intravenous chemotherapy" to "Category:Intravenous medications") |
m |
||
| Line 7: | Line 7: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| − | *[[ | + | *[[Ewing's sarcoma]] |
| + | *[[Osteosarcoma]] | ||
| + | *[[Sarcoma|Rhabdomyosarcoma]] | ||
*[[Uterine cancer]] | *[[Uterine cancer]] | ||
| Line 40: | Line 42: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| − | |||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| Line 46: | Line 47: | ||
[[Category:DNA synthesis inhibitors]] | [[Category:DNA synthesis inhibitors]] | ||
| − | [[Category: | + | [[Category:Osteosarcoma medications]] |
| + | [[Category:Ewing's sarcoma medications]] | ||
| + | [[Category:Sarcoma medications]] | ||
[[Category:Uterine cancer medications]] | [[Category:Uterine cancer medications]] | ||
[[Category:Drugs FDA approved in 1964]] | [[Category:Drugs FDA approved in 1964]] | ||
[[Category:WHO Essential Cancer Medicine]] | [[Category:WHO Essential Cancer Medicine]] | ||
Revision as of 23:44, 7 September 2017
General information
Class/mechanism: Antibiotic oncologic, intercalates between guanine and cytosine DNA base pairs, inhibiting DNA and RNA synthesis.[1][2]
Route: IV
Extravasation: vesicant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Dactinomycin (Cosmegen) patient drug information (Chemocare)[3]
- Dactinomycin (Cosmegen) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 12/10/1964: Initial FDA approval
Also known as
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| AC-DE | Actinomycin D | Actinomycin D Comp | Cosmegen | Dacmozen | |||
| Dactinomycin | K.U. Dactinomycin | Lyovac | Lyovac Cosmegen | Lyovac Cosmogen | |||
| Trav Dactinomycin | |||||||